Trexquant Investment LP Eagle Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 43,723 shares of EGRX stock, worth $28,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,723

Previous 52,953 17.43%

Holding current value

$28,419

Previous $296,000 45.27%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.71 - $6.07 $34,243 - $56,026	-9,230 Reduced 17.43%	43,723 $162,000
Q2 2024 Aug 13, 2024	SELL	$3.34 - $5.6 $121,873 - $204,338	-36,489 Reduced 40.8%	52,953 $296,000
Q1 2024 May 14, 2024	SELL	$4.26 - $6.51 $156,938 - $239,828	-36,840 Reduced 29.17%	89,442 $468,000
Q4 2023 Feb 09, 2024	BUY	$4.63 - $15.21 $273,609 - $898,834	59,095 Added 87.96%	126,282 $660,000
Q3 2023 Nov 13, 2023	BUY	$15.21 - $22.88 $211,571 - $318,260	13,910 Added 26.11%	67,187 $1.06 Million
Q2 2023 Aug 11, 2023	BUY	$17.74 - $31.87 $676,231 - $1.21 Million	38,119 Added 251.48%	53,277 $1.04 Million
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $379,859 - $516,736	15,158 New	15,158 $430,000
Q2 2021 Aug 12, 2021	SELL	$36.86 - $44.5 $406,455 - $490,701	-11,027 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$40.32 - $50.97 $444,608 - $562,046	11,027 New	11,027 $460,000
Q4 2020 Feb 11, 2021	SELL	$41.72 - $51.34 $790,760 - $973,098	-18,954 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$37.02 - $51.28 $701,677 - $971,961	18,954 New	18,954 $805,000
Q2 2020 Aug 07, 2020	SELL	$43.24 - $55.02 $853,514 - $1.09 Million	-19,739 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$34.37 - $60.07 $678,429 - $1.19 Million	19,739 New	19,739 $908,000
Q2 2019 Aug 09, 2019	SELL	$46.61 - $58.45 $407,977 - $511,612	-8,753 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$38.66 - $51.82 $489,126 - $655,626	-12,652 Reduced 59.11%	8,753 $442,000
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $657,177 - $1.21 Million	17,897 Added 510.18%	21,405 $862,000
Q3 2018 Nov 09, 2018	BUY	$66.65 - $83.86 $233,808 - $294,180	3,508 New	3,508 $243,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.59M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $8.46M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Eagle Pharmaceuticals, Inc. Transaction History